Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.

NCT02181465 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: G17DT

Sponsor

Cancer Advances Inc.